Cited by 63Context-Aware Activity Recognition SystemsBalance, Gait, and Falls PreventionParkinson's Disease Mechanisms and Treatments

Large-Scale Wearable Sensor Deployment in Parkinson’s Patients: The Parkinson@Home Study Protocol

Open access
Silva de Lima, Ana Lígia, Hahn, Tim, de Vries, Nienke M, Cohen, Eli, Bataille, Lauren, Little, Max A, Baldus, Heribert, Bloem, Bastiaan R +1 more·2016·JMIR Research Protocols

Abstract

BACKGROUND: Long-term management of Parkinson's disease does not reach its full potential because we lack knowledge about individual variations in clinical presentation and disease progression. Continuous and longitudinal assessments in real-life (ie, within the patients' own home environment) might fill this knowledge gap. OBJECTIVE: The primary aim of the Parkinson@Home study is to evaluate the feasibility and compliance of using multiple wearable sensors to collect clinically relevant data. Our second aim is to address the usability of these data for answering clinical research questions. Finally, we aim to build a database for future validation of novel algorithms applied to sensor-derived data from Parkinson's patients during daily functioning. METHODS: The Parkinson@Home study is a two-phase observational study involving 1000 Parkinson's patients and 250 physiotherapists. Disease status is assessed using a short version of the Parkinson's Progression Markers Initiative protocol, performed by certified physiotherapists. Additionally, participants will wear a set of sensors (smartwatch, smartphone, and fall detector), and use these together with a customized smartphone app (Fox Insight), 24/7 for 3 months. The sensors embedded within the smartwatch and fall detector may be used to estimate physical activity, tremor, sleep quality, and falls. Medication intake and fall incidents will be measured via patients' self-reports in the smartphone app. Phase one will address the feasibility of the study protocol. In phase two, mathematicians will distill relevant summary statistics from the raw sensor signals, which will be compared against the clinical outcomes. RESULTS: Recruitment of 300 participants for phase one was concluded in March, 2016, and the follow-up period will end in June, 2016. Phase two will include the remaining participants, and will commence in September, 2016. CONCLUSIONS: The Parkinson@Home study is expected to generate new insights into the feasibility of integrating self-collected information from wearable sensors into both daily routines and clinical practices for Parkinson's patients. This study represents an important step towards building a reliable system that translates and integrates real-life information into clinical decisions, with the long-term aim of delivering personalized disease management support. CLINICALTRIAL: ClinicalTrials.gov NCT02474329; https://clinicaltrials.gov/ct2/show/NCT02474329 (Archived at http://www.webcitation.org/6joEc5P1v).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2196/resprot.5990

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The Parkinson@home study deployed the Fox Wearable Companion app to 953 participants in the Netherlands and North America; adherence was 68% in the Netherlands and 62% in North America, and not affected by demographics, clinical characteristics, or attitude toward technology.

    “The Parkinson@home study26, 30 deployed the Fox Wearable Companion app to 953 participants in the Netherlands (13‐week study) and North America (6‐week study) to passively monitor behavior and rate the severity of selected symptoms. Adherence was 68% in the Netherlands and 62% in North America, and not affected by demographics, clinical characteristics, or attitude toward technology.26, 30”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [26]Schwab R England AC Projection technique for evaluating surgery in Parkinson's disease 1968 05 Third Symposium on Parkinson's Disease, Royal College of Surgeons May 20 1968 Edinburgh
  2. [28]Yesavage JA Geriatric Depression Scale Psychopharmacol Bull 1988 24 4 709 11 3249773 3249773

Cited by

Sorted by citations

Authors
Silva de Lima, A. L., Hahn, T., de Vries, N. M., Cohen, E., Bataille, L., Little, M. A., Baldus, H., Bloem, B. R., & Faber, M. J.
Affiliations
  • Radboud University Medical Center (NL)
  • Intel (Israel) (IL)
  • Michael J. Fox Foundation (US)
  • Aston University (GB)
  • Radboud University Nijmegen (NL)
Venue
JMIR Research Protocols
Published
2016-08-26
Volume
5
Issue
3
Pages
e172
ISSN
1929-0748 (ISSN-L)
OpenAlex
W2507704171
Cited by
63
References
39
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2023: 10 · 2022: 6 · 2021: 6 · 2020: 12 · 2019: 4 · 2018: 13 · 2017: 7 · 2016: 1
FWCI
5.62
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • JMIR Research Protocols (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Radboud Repository (Radboud University) (submittedVersion)
  • Radboud Repository (Radboud University) (submittedVersion, other-oa)
Funders
  • Intel Corporation
  • Parkinson's UK (J-1403, J-0901)
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (0428-140)
  • Stichting ParkinsonFonds
Topics
  • Physical Sciences › Computer Science › Computer Vision and Pattern Recognition › Context-Aware Activity Recognition Systems
  • Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Balance, Gait, and Falls Prevention
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
Keywords
Parkinson's disease, wearable sensors, home monitoring, smartwatches, fall detection, mobile application, physical activity, tremor, sleep quality, medication adherence, falls, Parkinson's Progression Markers Initiative, physiotherapists, feasibility, sensor data analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review